The New Frontier of Male Fertility: Lab-Grown Sperm View this post on Instagram about Paterna, Paterna Biosciences From Instagram — related to Paterna, Paterna Biosciences For years, the conversation around infertility has focused heavily on female reproductive health. However, data from the U.S. Department of Health and Human Services reveals a stark reality: more than … Read more
Beyond the On/Off Switch: The New Era of Gene Control For years, the scientific community viewed the epigenome primarily as a series of binary switches—proteins that either turned a gene “on” or “off.” However, groundbreaking research from North Carolina State University is rewriting this narrative. A recent study published in iScience reveals that epigenome regulators … Read more
Beyond Prosthetics: The Quest to Wake Up the Human Regeneration Switch For decades, the idea of regrowing a lost limb was relegated to the realm of comic books and high-concept science fiction. But recent breakthroughs in genetic research are shifting the conversation from “if” to “how.” The discovery of the SP8 gene—a molecular switch that … Read more
President Donald Trump has nominated Erica Schwartz to serve as the director of the Centers for Disease Control and Prevention (CDC), ending a months-long search for a permanent leader of the agency. Schwartz, who must be confirmed by the Senate, will enter the role as Health and Human Services Secretary Robert F. Kennedy Jr. Manages … Read more
AI-Powered Drug Discovery: Lilly and Insilico Medicine Forge a $2.75 Billion Partnership The pharmaceutical landscape is undergoing a seismic shift, driven by the integration of artificial intelligence (AI) into drug discovery. A recent collaboration between Eli Lilly and Insilico Medicine, valued at up to $2.75 billion, exemplifies this trend. The deal, announced on March 29, … Read more
Averna Therapeutics Bolsters Leadership: What It Signals for the Future of Gene Therapy Averna Therapeutics’ recent appointments of Robert Mabry as Chief Scientific Officer (CSO) and Richard Morris as Chief Financial Officer (CFO) aren’t just internal shifts; they represent a strategic move within the rapidly evolving landscape of genomic medicine. These hires, announced on March … Read more
Trump Administration Pushes for Legislative Drug Pricing Reform Washington D.C. – The White House is actively working to translate its voluntary drug pricing agreements with pharmaceutical companies into formal legislation. Officials are currently sharing draft legislative text with over a dozen major pharmaceutical companies, signaling a continued commitment to lowering prescription drug costs. Building on … Read more
The AI Revolution in Gastrointestinal Endoscopy: What’s Next? The field of gastrointestinal (GI) endoscopy is undergoing a rapid transformation, fueled by advancements in artificial intelligence (AI). From enhancing diagnostic accuracy to streamlining reporting processes, AI is poised to reshape how clinicians approach the detection and management of digestive diseases. Recent research highlights a clear trend: … Read more
China’s Biotech Rise: A Global Reshaping of Drug Development The biotech landscape is undergoing a significant shift, with China rapidly emerging as a dominant force. This ascent is not happening in isolation; it’s intertwined with challenges to global collaboration and a wave of consolidation within the industry. NIH Restrictions and the Impact on Global Research … Read more
FDA Greenlights First Gene Therapy for LAD-I: A Latest Era for Rare Disease Treatment In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved Kresladi (marnetegragene autotemcel), a gene therapy developed by Rocket Pharmaceuticals, for the treatment of severe Leukocyte Adhesion Deficiency Type I (LAD-I). This approval marks the first FDA-approved gene … Read more